Overexpression of FRA1 (FOSL1) Leads to Global Transcriptional Perturbations, Reduced Cellular Adhesion and Altered Cell Cycle Progression

FRA1 (FOSL1) is a transcription factor and a member of the activator protein-1 superfamily. FRA1 is expressed in most tissues at low levels, and its expression is robustly induced in response to extracellular signals, leading to downstream cellular processes. However, abnormal FRA1 overexpression has been reported in various pathological states, including tumor progression and inflammation. To date, the molecular effects of FRA1 overexpression are still not understood. Therefore, the aim of this study was to investigate the transcriptional and functional effects of FRA1 overexpression using the CGL1 human hybrid cell line. FRA1-overexpressing CGL1 cells were generated using stably integrated CRISPR-mediated transcriptional activation, resulting in a 2–3 fold increase in FRA1 mRNA and protein levels. RNA-sequencing identified 298 differentially expressed genes with FRA1 overexpression. Gene ontology analysis showed numerous molecular networks enriched with FRA1 overexpression, including transcription-factor binding, regulation of the extracellular matrix and adhesion, and a variety of signaling processes, including protein kinase activity and chemokine signaling. In addition, cell functional assays demonstrated reduced cell adherence to fibronectin and collagen with FRA1 overexpression and altered cell cycle progression. Taken together, this study unravels the transcriptional response mediated by FRA1 overexpression and establishes the role of FRA1 in adhesion and cell cycle progression.

[1]  D. Boreham,et al.  Genomic Loss and Epigenetic Silencing of the FOSL1 Tumor Suppressor Gene in Radiation-induced Neoplastic Transformation of Human CGL1 Cells Alters the Tumorigenic Phenotype In Vitro and In Vivo , 2023, Radiation Research.

[2]  Lei Jiang,et al.  Influence of FOSL1 Inhibition on Vascular Calcification and ROS Generation through Ferroptosis via P53-SLC7A11 Axis , 2023, Biomedicines.

[3]  Chao Zhang,et al.  FOSL1 knockdown ameliorates DSS-induced inflammation and barrier damage in ulcerative colitis via MMP13 downregulation , 2022, Experimental and therapeutic medicine.

[4]  Q. Liao,et al.  FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  N. Khaper,et al.  Identification of Radiation-Induced miRNA Biomarkers Using the CGL1 Cell Model System , 2022, Bioengineering.

[6]  A. Cimmino,et al.  The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting , 2022, Cancers.

[7]  N. Geppe,et al.  Role of the Transcription Factor FOSL1 in Organ Development and Tumorigenesis , 2022, International journal of molecular sciences.

[8]  S. Tharmalingam,et al.  Radiation-Induced Alterations in Proliferation, Migration, and Adhesion in Lens Epithelial Cells and Implications for Cataract Development , 2022, Bioengineering.

[9]  G. Schett,et al.  The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model , 2021, Frontiers in Immunology.

[10]  Y. Ishihara,et al.  FosL1 Is a Novel Target of Levetiracetam for Suppressing the Microglial Inflammatory Reaction , 2021, International journal of molecular sciences.

[11]  Junjie Chen,et al.  Genetic vulnerabilities upon inhibition of DNA damage response , 2021, Nucleic acids research.

[12]  John G Doench,et al.  SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization , 2021, Cell reports.

[13]  L. Farina,et al.  The role of FOSL1 in stem-like cell reprogramming processes , 2021, Scientific Reports.

[14]  Lei Wu,et al.  Inflammation and tumor progression: signaling pathways and targeted intervention , 2021, Signal Transduction and Targeted Therapy.

[15]  Kyu-Sang Park,et al.  Fosl1 is vital to heart regeneration upon apex resection in adult Xenopus tropicalis , 2021, NPJ Regenerative medicine.

[16]  J. Dopazo,et al.  A DNA damage repair gene‐associated signature predicts responses of patients with advanced soft‐tissue sarcoma to treatment with trabectedin , 2021, Molecular oncology.

[17]  J. Peterson,et al.  Transcriptomic Response in the Spleen after Whole-Body Low-Dose X-Ray Irradiation , 2021, Radiation Research.

[18]  K. Podar,et al.  The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology , 2021, Cancers.

[19]  Jill R. Johnson,et al.  Effects of cytokine signaling inhibition on inflammation-driven tissue remodeling , 2021, Current research in pharmacology and drug discovery.

[20]  Prashant Chauhan,et al.  A primer on cytokines. , 2021, Cytokine.

[21]  A. Sala,et al.  MYB oncoproteins: emerging players and potential therapeutic targets in human cancer , 2021, Oncogenesis.

[22]  H. Qiu,et al.  The Role of Cell Cycle Regulators in Cell Survival—Dual Functions of Cyclin-Dependent Kinase 20 and p21Cip1/Waf1 , 2020, International journal of molecular sciences.

[23]  T. Tai,et al.  Whole transcriptome analysis of adrenal glands from prenatal glucocorticoid programmed hypertensive rodents , 2020, Scientific Reports.

[24]  M. Smanski,et al.  CRISPR-Cas Activators for Engineering Gene Expression in Higher Eukaryotes. , 2020, The CRISPR journal.

[25]  M. Gao,et al.  Fra-1 Inhibits Cell Growth and the Warburg Effect in Cervical Cancer Cells via STAT1 Regulation of the p53 Signaling Pathway , 2020, Frontiers in Cell and Developmental Biology.

[26]  E. Wagner,et al.  Wnt signaling and Loxl2 promote aggressive osteosarcoma , 2020, Cell Research.

[27]  P. Verde,et al.  The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door , 2020, Oncogene.

[28]  D. Ribatti,et al.  Epithelial-Mesenchymal Transition in Cancer: A Historical Overview , 2020, Translational oncology.

[29]  N. Khaper,et al.  Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue , 2020, PloS one.

[30]  T. Tai,et al.  Effect of Prenatal Glucocorticoid Exposure on Circadian Rhythm Gene Expression in the Brains of Adult Rat Offspring , 2020, Cells.

[31]  N. Khaper,et al.  The Role of DNMT and HDACs in the Fetal Programming of Hypertension by Glucocorticoids , 2020, Oxidative medicine and cellular longevity.

[32]  Hui Xie,et al.  Expression and function of FRA1 protein in tumors , 2019, Molecular Biology Reports.

[33]  D. Boreham,et al.  Transcriptomic profiling of gamma ray induced mutants from the CGL1 human hybrid cell system reveals novel insights into the mechanisms of radiation-induced carcinogenesis. , 2019, Free radical biology & medicine.

[34]  T. Tai,et al.  Fetal programming of adrenal PNMT and hypertension by glucocorticoids in WKY rats is dose and sex-dependent , 2019, PloS one.

[35]  K. Zibara,et al.  The AP-1 transcriptional complex: Local switch or remote command? , 2019, Biochimica et biophysica acta. Reviews on cancer.

[36]  L. Ivashkiv,et al.  Interferon target-gene expression and epigenomic signatures in health and disease , 2019, Nature Immunology.

[37]  A. Ekici,et al.  Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis. , 2019, The Journal of clinical investigation.

[38]  A. Brooks,et al.  Re-evaluation of the linear no-threshold (LNT) model using new paradigms and modern molecular studies. , 2019, Chemico-biological interactions.

[39]  Jennifer Y. Zhang,et al.  UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling. , 2018, Cancer research.

[40]  W. Ni,et al.  The overexpression of Fra1 disorders the inflammatory cytokine secretion by mTEC of myasthenia gravis thymus , 2018, Scandinavian journal of immunology.

[41]  D. Sheppard,et al.  TGF-β1 Signaling and Tissue Fibrosis. , 2018, Cold Spring Harbor perspectives in biology.

[42]  Xiaofeng Liu,et al.  Reassessing the Potential of Myb-targeted Anti-cancer Therapy , 2018, Journal of Cancer.

[43]  J. Albeck,et al.  Linear Integration of ERK Activity Predominates over Persistence Detection in Fra-1 Regulation. , 2017, Cell systems.

[44]  Rong-zhan Fu,et al.  The regulatory role of Fos related antigen‑1 in inflammatory bowel disease. , 2017, Molecular medicine reports.

[45]  Minhui Xu,et al.  Downregulation of miR-16 via URGCP pathway contributes to glioma growth , 2017, Scientific Reports.

[46]  Xin-Hua Feng,et al.  AUNIP/C1orf135 directs DNA double-strand breaks towards the homologous recombination repair pathway , 2017, Nature Communications.

[47]  D. Boreham,et al.  The CGL1 (HeLa × Normal Skin Fibroblast) Human Hybrid Cell Line: A History of Ionizing Radiation Induced Effects on Neoplastic Transformation and Novel Future Directions in SNOLAB , 2017, Radiation Research.

[48]  Yibo Gao,et al.  High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation , 2017, Journal of experimental & clinical cancer research : CR.

[49]  M. Nykter,et al.  Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT , 2017, Oncogene.

[50]  K. Gallo,et al.  MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells , 2017, Oncogenesis.

[51]  Y. Ge,et al.  Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[52]  Wei Wang,et al.  DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression , 2017, Journal of cancer metastasis and treatment.

[53]  Andrei V Bakin,et al.  Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells , 2017, Oncotarget.

[54]  H. Nakano,et al.  Critical Contribution of Nuclear Factor Erythroid 2-related Factor 2 (NRF2) to Electrophile-induced Interleukin-11 Production* , 2016, The Journal of Biological Chemistry.

[55]  M. Peter,et al.  Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection , 2016, Nature Communications.

[56]  M. Hollingsworth,et al.  Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis , 2016, Oncotarget.

[57]  D. Hampson,et al.  The calcium‐sensing receptor and integrins modulate cerebellar granule cell precursor differentiation and migration , 2016, Developmental neurobiology.

[58]  L. Wessels,et al.  Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival , 2015, Oncotarget.

[59]  Z. Zeng,et al.  Fra-1 is upregulated in gastric cancer tissues and affects the PI3K/Akt and p53 signaling pathway in gastric cancer. , 2015, International journal of oncology.

[60]  M. Weiss,et al.  Dysregulation of the Transforming Growth Factor β Pathway in Induced Pluripotent Stem Cells Generated from Patients with Diamond Blackfan Anemia , 2015, PloS one.

[61]  P. Das,et al.  Transcriptional Control of Mitosis: Deregulation and Cancer , 2015, Front. Endocrinol..

[62]  Melissa J. Davis,et al.  Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines , 2015, Cell Communication and Signaling.

[63]  M. Xue,et al.  Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro. , 2015, International journal of oncology.

[64]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[65]  E. Wagner,et al.  Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression , 2014, Cell Death and Differentiation.

[66]  L. Yang,et al.  Roles of tumor suppressors in regulating tumor-associated inflammation , 2014, Cell Death and Differentiation.

[67]  Aly A. Khan,et al.  Gene regulatory networks in the immune system. , 2014, Trends in immunology.

[68]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[69]  Morgan L. Maeder,et al.  CRISPR RNA-guided activation of endogenous human genes , 2013, Nature Methods.

[70]  S. Oliviero,et al.  Role of the AP-1 transcription factor FOSL1 in endothelial cells adhesion and migration , 2013, Cell adhesion & migration.

[71]  E. Wagner,et al.  FOSL1 Controls the Assembly of Endothelial Cells into Capillary Tubes by Direct Repression of αv and β3 Integrin Transcription , 2013, Molecular and Cellular Biology.

[72]  A. Dhillon,et al.  Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL , 2012, Oncogene.

[73]  S. Angers,et al.  Calcium-sensing Receptor Modulates Cell Adhesion and Migration via Integrins* , 2011, The Journal of Biological Chemistry.

[74]  E. Wagner,et al.  Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1 , 2011, Oncogene.

[75]  R. Janknecht,et al.  Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. , 2011, Biochimica et biophysica acta.

[76]  E. Wagner,et al.  Elevated Fra-1 expression causes severe lipodystrophy , 2011, Journal of Cell Science.

[77]  T. Boehm,et al.  Essential role of c-myb in definitive hematopoiesis is evolutionarily conserved , 2010, Proceedings of the National Academy of Sciences.

[78]  T. Mega,et al.  Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein , 2010, Oncogene.

[79]  P. Raychaudhuri,et al.  DDB2 (Damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response , 2009, Cell cycle.

[80]  C. Prives,et al.  Stxbp4 Regulates ΔNp63 Stability by Suppression of RACK1-Dependent Degradation , 2009, Molecular and Cellular Biology.

[81]  H. Kuwata,et al.  Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses. , 2009, International immunology.

[82]  Zhihua Liu,et al.  Expression and Significance of FRA-1 in Non-Small-Cell Lung Cancer , 2009, Cancer investigation.

[83]  J. O’Shea,et al.  Cytokine signaling modules in inflammatory responses. , 2008, Immunity.

[84]  P. Verde,et al.  Fra‐1 promotes growth and survival in RAS‐transformed thyroid cells by controlling cyclin A transcription , 2007, The EMBO journal.

[85]  E. Wagner,et al.  Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. , 2007, Bone.

[86]  R. Hipskind,et al.  Ubiquitin-Independent Proteasomal Degradation of Fra-1 Is Antagonized by Erk1/2 Pathway-Mediated Phosphorylation of a Unique C-Terminal Destabilizer , 2007, Molecular and Cellular Biology.

[87]  S. Weiss,et al.  A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells , 2006, Nature Cell Biology.

[88]  H. Hanafusa,et al.  FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[89]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[90]  P. Jackson,et al.  The Evi5 Oncogene Regulates Cyclin Accumulation by Stabilizing the Anaphase-Promoting Complex Inhibitor Emi1 , 2006, Cell.

[91]  S. Weiss,et al.  Wnt-dependent Regulation of the E-cadherin Repressor Snail* , 2005, Journal of Biological Chemistry.

[92]  K. Belguise,et al.  FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells , 2005, Oncogene.

[93]  E. Wagner,et al.  The Fos‐related antigen Fra‐1 is an activator of bone matrix formation , 2004, The EMBO journal.

[94]  E. Stanbridge,et al.  Homozygous deletions within the 11q13 cervical cancer tumor‐suppressor locus in radiation‐induced, neoplastically transformed human hybrid cells , 2004, Genes, chromosomes & cancer.

[95]  N. Shirsat,et al.  Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of c6 glioma cells. , 2003, Experimental cell research.

[96]  E. Nishida,et al.  Regulation of c‐Fos and Fra‐1 by the MEK5‐ERK5 pathway , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[97]  A. Yoshimura,et al.  Regulation of cytokine signaling and inflammation. , 2002, Cytokine & growth factor reviews.

[98]  M. Ginsberg,et al.  α4 integrins and the immune response , 2002, Immunological reviews.

[99]  N. Colburn,et al.  Transactivation of Fra-1 and Consequent Activation of AP-1 Occur Extracellular Signal-Regulated Kinase Dependently , 2002, Molecular and Cellular Biology.

[100]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[101]  E. Lee,et al.  Fra-1 Expression in Malignant and Benign Thyroid Tumor , 2001, The Korean journal of internal medicine.

[102]  G Melino,et al.  Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. , 2001, The Biochemical journal.

[103]  E. Wagner,et al.  Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 , 2000, Nature Medicine.

[104]  E. Wagner,et al.  Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation , 2000, Nature Genetics.

[105]  R. Wisdom,et al.  AP-1: one switch for many signals. , 1999, Experimental cell research.

[106]  J. Yagüe,et al.  Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. , 1999, Blood.

[107]  M. Mendonca,et al.  Previous loss of chromosome 11 containing a suppressor locus increases radiosensitivity, neoplastic transformation frequency and delayed death in HeLa x fibroblast human hybrid cells. , 1999, Mutagenesis.

[108]  S. Agrawal,et al.  Dual Blockade of Cyclic AMP Response Element- (CRE) and AP-1-directed Transcription by CRE-transcription Factor Decoy Oligonucleotide , 1999, The Journal of Biological Chemistry.

[109]  H. Hwang,et al.  gas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[110]  B. Williams,et al.  Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. , 1998, Human molecular genetics.

[111]  A. Feinberg,et al.  A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. , 1997, Genomics.

[112]  Y. Takada,et al.  Multiple loop structures critical for ligand binding of the integrin α4 subunit in the upper face of the β-propeller mode 1 , 1997 .

[113]  E. Zandi,et al.  AP-1 function and regulation. , 1997, Current opinion in cell biology.

[114]  S. Busch,et al.  DNA binding of Jun and Fos bZip domains: homodimers and heterodimers induce a DNA conformational change in solution. , 1996, Nucleic acids research.

[115]  J. N. Mark Glover,et al.  Crystal structure of the heterodimeric bZIP transcription factor c-Fos–c-Jun bound to DNA , 1995, Nature.

[116]  E. Stanbridge,et al.  Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids. , 1991, Cancer research.

[117]  B. Franza,et al.  The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. , 1989, Genes & development.

[118]  Michael E. Greenberg,et al.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities , 1988, Cell.

[119]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[120]  E. Stanbridge,et al.  Neoplastic transformation of human hybrid cells by gamma radiation: a quantitative assay. , 1987, Radiation research.

[121]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[122]  E. Stanbridge,et al.  Radiobiological studies of human hybrid cells (skin fibroblasts X HeLa) and their tumourigenic segregants. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.